Delivery Order SPE2DB22D2206-SPE2DB26FDU60
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $25,717.85 to AmerisourceBergen Drug Corp for the supply of AYVAKIT (avapritinib) 200 mg tablets in a 30-count configuration. This firm fixed-price delivery order, issued on November 25, 2025, with an ultimate completion date of December 17, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $51,362.20 to AmerisourceBergen Drug Corp for AYVAKIT (avapritinib) 25 mg tablets in a quantity of 30 units. The contract, issued on December 17, 2025, represents a firm fixed-price delivery order with an ultimate completion date of January 9, 2026. This award was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $24,368.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AYVAKIT 25 mg tablets (30-count supply) on August 19, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside contract represents a pediatric cancer medication delivery supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a $25,717.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of AYVAKIT 200 mg tablets (30-count units) with a completion date of January 15, 2026. The award was competitively procured with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is valued at $23,325.68. It is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to provide the pharmaceutical product AYVAKIT 25 MG TABLET 30S. The contract has a June 2024 completion date and is not associated with a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $116,628.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of the pharmaceutical product AYVAKIT 25 MG TABLET 30S. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of August 21, 2024. Amerisourcebergen, a major pharmaceutical distributor, supplies essential medical commodities to various federal agencies and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for AYVAKIT 25 mg tablets (30-count packages) valued at $25,681.09 under a firm fixed-price contract type. The award was made on December 3, 2025, with an ultimate completion date of December 24, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order and is a major pharmaceutical distributor...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,675.50 Firm Fixed Price Delivery Order is for the supply of AYVAKIT 300 MG TABLET 30S, a pharmaceutical product, with a performance period through July 14, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AYVAKIT 300 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $24,675.50 and a performance period ending on July 30, 2025. The contract is a firm fixed-price delivery order, which means Amerisourcebergen will provide the specified product at a pre-determined price....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,368.92, is for the delivery of 4568149543 AYVAKIT 25 MG TABLET 30S, a prescription medication. The contract has a period of performance through May 23, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDU60Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $24,403.80 by the Defense Logistics Agency on October 28, 2025, for the supply of Ayvakit 200 mg tablets (30-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 19, 2025. The contract is a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. The delivery order represents a routine pharmaceutical procurement through DLA's Medical Supply Chain, which utilizes AmerisourceBergen's IDC to fulfill critical pharmaceutical needs across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Ayvakit (ripretinib) is a tyrosine kinase inhibitor indicated for advanced gastrointestinal stromal tumors, reflecting the specialized pharmaceutical capabilities maintained under this contract vehicle. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capacity to meet competitive procurement requirements for brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains in support of military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.4k | 10/28/25 |